Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / Life Science History - Page 53

Life Science History

HDT BIO received NIH contract to advance novel RNA/LIONル COVID-19 vaccine into clinical trials
COVID-19 | Life Science History | Vaccine

HDT BIO received NIH contract to advance novel RNA/LIONル COVID-19 vaccine into clinical trials

On Sept. 1, 2020, HDT Bio received a notice of award from the National Institute of Allergy and…

Read More HDT BIO received NIH contract to advance novel RNA/LIONル COVID-19 vaccine into clinical trialsContinue

Atossa Therapeutics announced positive safety assessment in clinical study of COVID-19 AT-301 nasal spray
Life Science History

Atossa Therapeutics announced positive safety assessment in clinical study of COVID-19 AT-301 nasal spray

On Sept. 1, 2020, Atossa Therapeutics announced a positive interim safety assessment from the first cohort of healthy…

Read More Atossa Therapeutics announced positive safety assessment in clinical study of COVID-19 AT-301 nasal sprayContinue

Phase 3 clinical testing in the US of AstraZeneca COVID-19 vaccine candidate began
COVID-19 | Life Science History | Vaccine

Phase 3 clinical testing in the US of AstraZeneca COVID-19 vaccine candidate began

On Aug. 31, 2020, a multi-site, Phase 3 clinical trial evaluating an investigational COVID-19 vaccine known as AZD1222…

Read More Phase 3 clinical testing in the US of AstraZeneca COVID-19 vaccine candidate beganContinue

Vir Biotechnology and GSK started phase 2/3 study of COVID-19 antibody treatment
Biotechnology | COVID-19 | Life Science History

Vir Biotechnology and GSK started phase 2/3 study of COVID-19 antibody treatment

On Aug. 31, 2020, Vir Biotechnology and GlaxoSmithKline announced that the first patient was dosed in a phase…

Read More Vir Biotechnology and GSK started phase 2/3 study of COVID-19 antibody treatmentContinue

Philips EV300 ventilator supply contract with US Department of Health and Human Services to end
Life Science History

Philips EV300 ventilator supply contract with US Department of Health and Human Services to end

On Aug. 31, 2020, Royal Philips announced that it had received notice from the U.S. Department of Health…

Read More Philips EV300 ventilator supply contract with US Department of Health and Human Services to endContinue

UConn launched funding program for COVID-19 research
Life Science History

UConn launched funding program for COVID-19 research

On Aug. 31, 2020, the Office of the Vice President for Research (OVPR) announced it had launched a…

Read More UConn launched funding program for COVID-19 researchContinue

T2 Biosystems received FDA Emergency Use Authorization for COVID-19 molecular diagnostic test
COVID-19 | FDA | Life Science History

T2 Biosystems received FDA Emergency Use Authorization for COVID-19 molecular diagnostic test

On Aug. 31, 2020, T2 Biosystems announced that the FDA had issued an Emergency Use Authorization (EUA) for…

Read More T2 Biosystems received FDA Emergency Use Authorization for COVID-19 molecular diagnostic testContinue

Todos Medical announced $23,760,000 contract for COVID-19 PCR testing equipment & supplies with Wisconsin-based laboratory
COVID-19 | Life Science History

Todos Medical announced $23,760,000 contract for COVID-19 PCR testing equipment & supplies with Wisconsin-based laboratory

On Aug. 31, 2020, Todos Medical announced that it had entered into a sales agreement with a Wisconsin-based…

Read More Todos Medical announced $23,760,000 contract for COVID-19 PCR testing equipment & supplies with Wisconsin-based laboratoryContinue

FDA expanded Emergency Use Authorization for Veklury (remdesivir) to include all hospitalized patients for treatment of COVID-19
COVID-19 | FDA | Life Science History

FDA expanded Emergency Use Authorization for Veklury (remdesivir) to include all hospitalized patients for treatment of COVID-19

On Aug. 28, 2020, the FDA issued an emergency use authorization (EUA) to Yale School of Public Health…

Read More FDA expanded Emergency Use Authorization for Veklury (remdesivir) to include all hospitalized patients for treatment of COVID-19Continue

The US Dept of Veterans Affairs anounced new clinical trial for Veterans with COVID-19
COVID-19 | Life Science History

The US Dept of Veterans Affairs anounced new clinical trial for Veterans with COVID-19

On Aug. 28, 2020, the U.S. Dept. of Veterans Affairs (VA) announced a new clinical trial to study…

Read More The US Dept of Veterans Affairs anounced new clinical trial for Veterans with COVID-19Continue

Gileadメs investigational antiviral Vekluryᆴ (remdesivir) received FDA Emergency Use Authorization for treatment of patients with moderate COVID-19
COVID-19 | FDA | Life Science History

Gileadメs investigational antiviral Vekluryᆴ (remdesivir) received FDA Emergency Use Authorization for treatment of patients with moderate COVID-19

On Aug. 28, 2020, Gilead Sciences announced the FDA expanded the Emergency Use Authorization (EUA) enabling use of…

Read More Gileadメs investigational antiviral Vekluryᆴ (remdesivir) received FDA Emergency Use Authorization for treatment of patients with moderate COVID-19Continue

iBio and Planet Biotechnology entered into exclusive worldwide license agreement for development of a COVID-19 therapeutic
Biotechnology | COVID-19 | Life Science History

iBio and Planet Biotechnology entered into exclusive worldwide license agreement for development of a COVID-19 therapeutic

On Aug. 28, 2020, iBio announced that it had entered into an exclusive worldwide license agreement with Planet…

Read More iBio and Planet Biotechnology entered into exclusive worldwide license agreement for development of a COVID-19 therapeuticContinue

NCI and Cancer Research UK launched Cancer Grand Challenges partnership to support bold new ideas for cancer research
Life Science History

NCI and Cancer Research UK launched Cancer Grand Challenges partnership to support bold new ideas for cancer research

On Aug. 27, 2020, the National Cancer Institute (NCI) announced a partnership with Cancer Research UK to fund…

Read More NCI and Cancer Research UK launched Cancer Grand Challenges partnership to support bold new ideas for cancer researchContinue

International research alliance launched to boost pandemic preparedness
Life Science History

International research alliance launched to boost pandemic preparedness

On Aug. 27, 2020, scientists at Scripps Research announced they were partnering with peers in the U.S. and…

Read More International research alliance launched to boost pandemic preparednessContinue

AIM ImmunoTech decreased SARS-CoV-2 infectious viral yields by 90% using new in vitro model
COVID-19 | Life Science History

AIM ImmunoTech decreased SARS-CoV-2 infectious viral yields by 90% using new in vitro model

On Aug. 27, 2020, AIM ImmunoTech announced that it had identified an effective in vitro model at The…

Read More AIM ImmunoTech decreased SARS-CoV-2 infectious viral yields by 90% using new in vitro modelContinue

Todos Medical announced $4,500,000 contract for COVID-19 PCR testing equipment & supplies with New York-based laboratory
Life Science History

Todos Medical announced $4,500,000 contract for COVID-19 PCR testing equipment & supplies with New York-based laboratory

On Aug. 27, 2020, Todos Medical announced it had entered into a sales agreement with a New York-based…

Read More Todos Medical announced $4,500,000 contract for COVID-19 PCR testing equipment & supplies with New York-based laboratoryContinue

BioNTech and Fosun Pharma to potentially supply 10 Million doses of  BNT162 mRNA-based vaccine candidate against SARS-CoV-2
Life Science History | Vaccine

BioNTech and Fosun Pharma to potentially supply 10 Million doses of BNT162 mRNA-based vaccine candidate against SARS-CoV-2

On Aug. 27, 2020, Pfizer and Shanghai Fosun Pharmaceutical announced an intended collaboration to supply 10 million doses…

Read More BioNTech and Fosun Pharma to potentially supply 10 Million doses of BNT162 mRNA-based vaccine candidate against SARS-CoV-2Continue

National Science Foundation advanced artificial intelligence research with new nationwide institutes
Life Science History

National Science Foundation advanced artificial intelligence research with new nationwide institutes

On Aug. 26, 2020, the National Science Foundation (NSF) announced that it was establishing new artificial intelligence institutes…

Read More National Science Foundation advanced artificial intelligence research with new nationwide institutesContinue

Abbott’s fast, $5, 15-minute, easy-to-use COVID-19 antigen test for healthcare professionals received FDA Emergency Use Authorization
COVID-19 | FDA | Life Science History

Abbott’s fast, $5, 15-minute, easy-to-use COVID-19 antigen test for healthcare professionals received FDA Emergency Use Authorization

On Aug. 26, 2020, Abbott announced the FDA had issued Emergency Use Authorization (EUA) for its BinaxNOWル COVID-19…

Read More Abbott’s fast, $5, 15-minute, easy-to-use COVID-19 antigen test for healthcare professionals received FDA Emergency Use AuthorizationContinue

UConn received federal funding to develop self-administered microneedle COVID-19 vaccine technology
COVID-19 | Life Science History | Vaccine

UConn received federal funding to develop self-administered microneedle COVID-19 vaccine technology

On Aug. 26, 2020, UConn announced that Thanh Duc Nguyen, Assistant Professor in the Departments of Mechanical Engineering…

Read More UConn received federal funding to develop self-administered microneedle COVID-19 vaccine technologyContinue

Altimmune and University of Alabama announced potent respiratory mucosal T cell responses in peclinical study of intranasal COVID-19 vaccine candidate
COVID-19 | Life Science History | Vaccine

Altimmune and University of Alabama announced potent respiratory mucosal T cell responses in peclinical study of intranasal COVID-19 vaccine candidate

On Aug. 26, 2020, Altimmune announced additional positive results from the preclinical studies of its single-dose intranasal COVID-19…

Read More Altimmune and University of Alabama announced potent respiratory mucosal T cell responses in peclinical study of intranasal COVID-19 vaccine candidateContinue

Journal of American College of Cardiology published pioneering study using Stereotaxis robotic technology to treat pulmonary hypertension
Life Science History

Journal of American College of Cardiology published pioneering study using Stereotaxis robotic technology to treat pulmonary hypertension

On Aug. 26, 2020, Stereotaxis announced a pioneering publication in the prestigious Journal of the American College of…

Read More Journal of American College of Cardiology published pioneering study using Stereotaxis robotic technology to treat pulmonary hypertensionContinue

VBI Vaccines announced preclinical Coronavirus program data and selection of clinical candidates with potential one-dose vaccines
Life Science History | Vaccine

VBI Vaccines announced preclinical Coronavirus program data and selection of clinical candidates with potential one-dose vaccines

On Aug. 26, 2020, VBI Vaccines announced data from three preclinical mouse studies conducted to enable selection of…

Read More VBI Vaccines announced preclinical Coronavirus program data and selection of clinical candidates with potential one-dose vaccinesContinue

Heat Biologics’ announced publication of preclinical COVID-19 vaccine results
COVID-19 | Life Science History

Heat Biologics’ announced publication of preclinical COVID-19 vaccine results

On Aug. 26, 2020, Heat Biologics announced publication of positive preclinical COVID-19 results in bioRxiv. The company reported…

Read More Heat Biologics’ announced publication of preclinical COVID-19 vaccine resultsContinue

Phase I clinical trial initiated for monoclonal antibody combination for the prevention and treatment of COVID-19
COVID-19 | Life Science History

Phase I clinical trial initiated for monoclonal antibody combination for the prevention and treatment of COVID-19

On Aug. 25, 2020, AstraZeneca announced that the first participants have been dosed in a Phase I trial…

Read More Phase I clinical trial initiated for monoclonal antibody combination for the prevention and treatment of COVID-19Continue

Sinovac signed agreement with Bio Farma Indonesia for COVID-19 vaccine cooperation
COVID-19 | Life Science History | Vaccine

Sinovac signed agreement with Bio Farma Indonesia for COVID-19 vaccine cooperation

On Aug. 25, 2020, Sinovac Biotech announced it had signed two agreements in Hainan, China with PT Bio…

Read More Sinovac signed agreement with Bio Farma Indonesia for COVID-19 vaccine cooperationContinue

Intravacc and Therapyx jointly developed the world’s first prophylactic gonorrhea vaccine
Life Science History | Vaccine

Intravacc and Therapyx jointly developed the world’s first prophylactic gonorrhea vaccine

On Aug. 25, 2020, Intravacc announced that it had partnered with American, Buffalo, NY, based Therapyx, to further…

Read More Intravacc and Therapyx jointly developed the world’s first prophylactic gonorrhea vaccineContinue

Codex DNA building worldメs first vaccine printer and global vaccine network
Life Science History | Vaccine

Codex DNA building worldメs first vaccine printer and global vaccine network

On Aug. 25, 2020, Codex DNA announced critical advancements in its development of the Digital-to-Biological Converterル (DBC) platform….

Read More Codex DNA building worldメs first vaccine printer and global vaccine networkContinue

Catalent signed agreement with AstraZeneca to expand manufacturing support for COVID-19 vaccine AZD1222
COVID-19 | Life Science History | Vaccine

Catalent signed agreement with AstraZeneca to expand manufacturing support for COVID-19 vaccine AZD1222

On Aug. 24, 2020, Catalent announced that it had contracted to provide drug substance manufacturing to AstraZeneca for…

Read More Catalent signed agreement with AstraZeneca to expand manufacturing support for COVID-19 vaccine AZD1222Continue

Trevena announced initiation of TRV027 study in COVID-19 patients in collaboration with Imperial College London
COVID-19 | Life Science History

Trevena announced initiation of TRV027 study in COVID-19 patients in collaboration with Imperial College London

On Aug. 24, 2020,Trevena announced that Imperial College London (ICL) had initiated a proof-of-concept study for TRV027 in…

Read More Trevena announced initiation of TRV027 study in COVID-19 patients in collaboration with Imperial College LondonContinue

Page navigation

Previous PagePrevious 1 … 51 52 53 54 55 … 168 Next PageNext
  • Categories
  • Timeline
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cardiovascular
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemical
  • Clinical Research
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Banner Advertising

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search